Visgenx
Biotechnology Research • 
Santa Cruz, California, United States • 1-10 Employees
Company overview
| Headquarters | 250 Natural Bridges Dr, Santa Cruz, California 95060, US |
| Website | |
| NAICS | 541714 |
| Keywords | Gene Therapy |
| Founded | 2018 |
| Employees | 1-10 |
| Socials |
Key Contact at Visgenx
William Pedranti
Chief Executive Officer
Visgenx Email Formats
Visgenx uses 1 email format. The most common is {first initial} (e.g., j@visgenx.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial} | j@visgenx.com | 100% |
About Visgenx
Visgenx is developing therapeutics based on increasing expression of a gene known as ELOVL2 which has been shown to regulate aging in the retina and other tissues. Our lead indication is Dry Age-Related Macular Degeneration (Dry AMD).
$
Visgenx revenue & valuation
| Annual revenue | $171,110 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $547,552 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
C-Suite
Employees by Department
Visgenx has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Visgenx has never raised funding before.
Spain
Hong Kong
Italy
Germany
Frequently asked questions
Visgenx is located in Santa Cruz, California, US.
Visgenx was founded in 2018, making it 8 years old. The company has established itself as a significant player in its industry over this time.
Visgenx has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
4.8
40,000 users
